U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

First-Time Generics - June 2002

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, U 200 MG/28.5 MG (BASE)/5 ML, AND 400 MG/57 MG (BASE)/5 ML GENEVA PHARMACEUTICALS, INC. AUGMENTIN 200 MG/5 ML AND AUGMENTIN 400 MG/5 6/5/02
2 LEVOTHYROXINE SODIUM TABLETS, USP 0.025 MG, 0.05 MG, 0.075 MG, 0.088 MG, 0.1 MG, 0.112 MG, 0.125 MG, 0.15 MG, 0.175 MG, 0.2 MG, AND 0.3 MG MYLAN PHARMACEUTICALS INC. UNITHROID TABLETS 6/5/02
3 LITHIUM CARBONATE EXTENDED-RELEASE TABLETS, USP 300 MG BARR LABORATORIES, INC. LITHOBID SLOW-RELEASE TABLETS 6/10/02
4 TRETINOIN GEL, USP 0.01% SPEAR PHARMACEUTICALS, INC. RETIN-A GEL 6/11/02
5 AMMONIUM LACTATE LOTION 12% (BASE) PADDOCK LABORATORIES, INC. LAC-HYDRIN LOTION 6/11/02
6 TRAMADOL HYDROCHLORIDE TABLETS 50 MG PUREPAC PHARMACEUTICAL CO. ULTRAM TABLETS 6/19/02
7 TIZANIDINE HYDROCHLORIDE TABLETS 4 MG (BASE) EON LABS, INC. ZANAFLEX TABLETS 6/27/02
8 PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION 5 MG (BASE)/5 ML MORTON GROVE PHARMACEUTICALS, INC. PEDIAPRED ORAL SOLUTION 6/28/02

totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: April 25, 2006
Originator: OGC
HTML by PKS, TA